Table 1 Patients' baseline characteristics at the time of sampling
Parameter | Category | CLL (n=406) |
|---|---|---|
Gender | % male/female | 57/43 |
Age (years) | Median (range) | 66 (19–94) |
Time from diagnosis to sampling (months) | ⩽12 | 206 |
>12 | 200 | |
Binet stage | A | 315 |
B | 52 | |
C | 15 | |
Unknown | 24 | |
Rai stage | 0 | 254 |
I–II | 110 | |
III–IV | 17 | |
Unknown | 25 | |
Copy number alterations | tri(12) | 54/376 (14.3%) |
del(13q) | 163/376 (43.4%) | |
del(17p) | 15/376 (4%) | |
del(11q) | 37/376 (9.8%) | |
IGHV mutational status | Mutated | 218/382 (57.1%) |
Patients treated during follow-up | n (%) | 211/406 (53%) |
Follow-up from sampling (years) | Median (range) | 4.3 (0.01–19.1) |
